NXTC – Nextcure Inc
NXTC
$0.4485Name : NextCure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $12,580,515.00
EPSttm : -1.77
NextCure, Inc.
$0.4485
Float Short %
0.84
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.01
EPS Last/This Y
0.4
EPS This/Next Y
0.16
Price
0.45
Target Price
3
Analyst Recom
1
Performance Q
-40.44
Relative Volume
0.52
Beta
1.03
Ticker: NXTC
22 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-04-14 | NXTC | 0.32 | 0.00 | 0.00 | 46 |
2025-04-15 | NXTC | 0.3301 | 0.00 | 0.00 | 47 |
2025-04-16 | NXTC | 0.3224 | 0.00 | 0.00 | 47 |
2025-04-17 | NXTC | 0.3519 | 0.00 | 0.00 | 47 |
2025-04-18 | NXTC | 0.3612 | 0.00 | 0.00 | 47 |
2025-04-21 | NXTC | 0.3758 | 0.00 | 0.00 | 47 |
2025-04-22 | NXTC | 0.391 | 0.00 | 0.00 | 37 |
2025-04-23 | NXTC | 0.4275 | 0.00 | 0.00 | 37 |
2025-04-24 | NXTC | 0.3837 | 0.00 | 0.00 | 38 |
2025-04-25 | NXTC | 0.46 | 0 | 0 | 38 |
2025-04-28 | NXTC | 0.4648 | 0 | 0 | 38 |
2025-04-29 | NXTC | 0.4833 | 0.00 | 0.00 | 39 |
2025-04-30 | NXTC | 0.4705 | 0.00 | 0.00 | 39 |
2025-05-01 | NXTC | 0.47 | 0.00 | 0.00 | 39 |
2025-05-02 | NXTC | 0.4617 | 0.00 | 0.00 | 39 |
2025-05-05 | NXTC | 0.4499 | 0.00 | 0.00 | 39 |
2025-05-06 | NXTC | 0.43 | 0.00 | 0.00 | 40 |
2025-05-07 | NXTC | 0.351 | 0.00 | 0.00 | 40 |
2025-05-08 | NXTC | 0.3864 | 0.00 | 0.00 | 40 |
2025-05-09 | NXTC | 0.4164 | 0.00 | 0.00 | 40 |
2025-05-12 | NXTC | 0.4101 | 0.00 | 0.00 | 40 |
2025-05-13 | NXTC | 0.4439 | 0.00 | 0.00 | 41 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-04-14 | NXTC | 0.31 | 23.4 | - | -1.75 |
2025-04-15 | NXTC | 0.33 | 23.4 | - | -1.75 |
2025-04-16 | NXTC | 0.34 | 23.4 | - | -1.75 |
2025-04-17 | NXTC | 0.36 | 23.4 | - | -1.75 |
2025-04-18 | NXTC | 0.36 | 23.4 | - | -1.75 |
2025-04-21 | NXTC | 0.39 | 23.4 | - | -1.75 |
2025-04-22 | NXTC | 0.40 | 23.4 | - | -1.75 |
2025-04-23 | NXTC | 0.42 | 23.4 | - | -1.75 |
2025-04-24 | NXTC | 0.40 | 23.4 | - | -1.75 |
2025-04-25 | NXTC | 0.46 | 23.4 | - | -1.75 |
2025-04-28 | NXTC | 0.46 | 23.4 | - | -1.75 |
2025-04-29 | NXTC | 0.49 | 23.4 | - | -1.75 |
2025-04-30 | NXTC | 0.47 | 23.4 | - | -1.75 |
2025-05-01 | NXTC | 0.48 | 23.4 | - | -1.75 |
2025-05-02 | NXTC | 0.44 | 23.4 | - | -1.75 |
2025-05-05 | NXTC | 0.45 | 22.7 | - | -1.75 |
2025-05-06 | NXTC | 0.41 | 22.7 | - | -1.75 |
2025-05-07 | NXTC | 0.38 | 22.7 | - | -1.75 |
2025-05-08 | NXTC | 0.38 | 22.7 | - | -1.75 |
2025-05-09 | NXTC | 0.45 | 22.7 | - | -1.58 |
2025-05-12 | NXTC | 0.43 | 22.7 | - | -1.58 |
2025-05-13 | NXTC | 0.45 | 30.0 | - | -1.58 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-04-14 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-15 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-16 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-17 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-18 | NXTC | 0.00 | -15.24 | 0.27 |
2025-04-21 | NXTC | 0.00 | -15.75 | 0.27 |
2025-04-22 | NXTC | 0.00 | -15.75 | 0.27 |
2025-04-23 | NXTC | 0.00 | -15.75 | 0.27 |
2025-04-24 | NXTC | 0.00 | -15.75 | 0.27 |
2025-04-25 | NXTC | 0.00 | -15.75 | 0.27 |
2025-04-28 | NXTC | 0.00 | -15.90 | 0.16 |
2025-04-29 | NXTC | 0.00 | -15.90 | 0.16 |
2025-04-30 | NXTC | 0.00 | -15.90 | 0.16 |
2025-05-01 | NXTC | 0.00 | -15.90 | 0.16 |
2025-05-02 | NXTC | 0.00 | -15.90 | 0.16 |
2025-05-05 | NXTC | 0.00 | -15.92 | 0.16 |
2025-05-06 | NXTC | 0.00 | -15.92 | 0.16 |
2025-05-07 | NXTC | 0.00 | -15.92 | 0.16 |
2025-05-08 | NXTC | 0.00 | -15.92 | 0.16 |
2025-05-09 | NXTC | 0.00 | -15.92 | 0.16 |
2025-05-12 | NXTC | 0.00 | -21.22 | 0.84 |
2025-05-13 | NXTC | 0.00 | -21.22 | 0.84 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.39
Avg. EPS Est. Current Quarter
-0.39
Avg. EPS Est. Next Quarter
-0.39
Insider Transactions
Institutional Transactions
-21.22
Beta
1.03
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
6
Growth Score
21
Sentiment Score
51
Actual DrawDown %
98.8
Max Drawdown 5-Year %
-99.3
Target Price
3
P/E
Forward P/E
PEG
P/S
P/B
0.22
P/Free Cash Flow
EPS
-1.77
Average EPS Est. Cur. Y
-1.58
EPS Next Y. (Est.)
-1.43
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.52
Return on Equity vs Sector %
-112.4
Return on Equity vs Industry %
-95.4
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.16
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 43
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading